肥胖的肠道营养吸收失调与改变的染色质可访问性有关
Dilhana S Badurdeen1, Zhen Li1, Jeong-Heon Lee2
1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
概括
超吸收性表型的肥胖个体在肠道中增加了营养物质的吸收. 这与特定的基因表达变化和肠细胞中的染色质可访问性有关,为肥胖提供了新的治疗点.
科学领域:
- 胃肠病学 胃肠病学
- 代谢疾病 代谢疾病
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 肥胖是一个广泛的流行病,带有各种健康后果.
- 个体肥胖现象型及其治疗反应的了解很少.
- 在多种组织中观察到肥胖的表观遗传变化,但肠道上皮特征仍然不清楚.
研究的目的:
- 研究来自非肥胖,肥胖和肥胖过度吸收个体的肠道器官的转录和表观遗传学特征.
- 确定与肠道肥胖过度吸收现象型相关的分子特征.
主要方法:
- 从通过BMI和葡萄糖运输测定分类的捐赠者中确定了人类肠道有机体.
- 进行了转录基因分析 (基因表达) 和染色质可访问性测试.
- 用转录因子结合和定量RT-PCR来验证发现.
主要成果:
- 肥胖的超吸收性有机体表现出上调的营养吸收转录和下调的I型干扰素标.
- 建议增强的HNF4G结合可能驱动过度吸收表型.
- 在肠道上皮质中CUBN,GIP,SLC5A11和SLC2A5的表达与过度吸收有很强的相关性.
结论:
- 肥胖的超吸收表型的特点是转录转移促进了肠道营养吸收的增加.
- 不同的染色质可访问性可能是这些转录变化的基础.
- 在肥胖症中识别出不同的肠道表型,可以提供新的治疗策略.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Glucose Absorption Into the Small Intestine
34.7K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.7K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Spreading of Chromatin Modifications
9.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.3K


